Kirby Institute

What Kirby Institute does

The Kirby Institute is a health research institute embedded within UNSW Sydney (Kensington, NSW, Australia), founded in 1986 as the National Centre for HIV Epidemiology and Clinical Research (NCHECR) and renamed in 2011. It operates 14 research programs staffed by 300+ researchers and students, working to eliminate infectious diseases globally with primary focus areas spanning HIV, viral hepatitis, sexually transmissible infections, HPV, COVID-19 and emerging infections, First Nations health, and global health. Core technical capabilities sit in epidemiology and surveillance, clinical trials and cohorts, immunovirology, biostatistics and modelling, public health interventions, and novel diagnostics; the institute houses a state-of-the-art PC3 containment laboratory on the UNSW campus and has patented novel CD4+ T cell immunological assays that have been commercially developed.

Its "products" are research outputs rather than commercial goods: peer-reviewed publications, surveillance reports, the interactive data.kirby.unsw.edu.au portal, policy guidance, and training programs (notably the Cooper HIV/AIDS Research Training (CHART) Program and the David Cooper Scholarship). Distribution is academic and government-facing, with 1000+ collaborations across 53 countries and formalized partnerships spanning UNSW Medicine and Health, St Vincent's Centre for Applied Medical Research, NSW Health (HIV Reference Laboratory), WHO, The Global Fund, the Fiji Ministry of Health, and Australian injecting-drug-user advocacy organizations.

The institute is funded primarily through competitive Australian Government research grants (NHMRC, MRFF, Department of Health), with additional support from international bodies (WHO, The Global Fund) and donor/ philanthropy streams. In 2024 it reported over $47M AUD in new and continuing external grants. There is no commercial pricing model; the institute operates within UNSW's academic infrastructure and is governed by a Director (Scientia Professor Anthony Kelleher since 2019), a newly established External Advisory Committee chaired by Ms Lucy Hughes Turnbull AO, and a leadership group headed by the Director and Program Heads including Professor Rowena Bull (VISP).

Name

Kirby Institute

Legal name

Kirby Institute at UNSW Sydney

Website

https://kirby.unsw.edu.au

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

101–250 employees

Short description

The Kirby Institute is a UNSW Sydney-based health research institute founded in 1986 that works to eliminate infectious diseases, conducting epidemiology, clinical trials, and immunovirology research on HIV, viral hepatitis, STIs, and emerging infections across 53 countries.

Ownership category

akta.pro rank

Product category

Infectious Disease Research

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

General Infectious Disease (HLAKAGAA)

akta.pro secondary industries

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), Disease Surveillance, Epidemiology & Outbreak Response (BPAIAJAA), Infectious Disease Program Evaluation (e.g., HIV/TB/Malaria/STIs) (HLAJANAF), Health Security, Pandemic Preparedness & Response (IHR, EID) (BPADAIAH)

Keywords

• Infectious disease research
• HIV clinical trials
• Viral hepatitis epidemiology
• Immunovirology research
• Global health surveillance

Headquarters

HQ city

Kensington

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Government Research Funding: Primary funding from Australian Government through grants including NHMRC and MRFF. In 2024, awarded over $47 million in research funding from new and continuing external grants.
2. Project-Specific Grants: Received nearly $5 million from Australian Government for hepatitis C testing expansion project targeting community and prison populations.
3. International Organization Funding: Funding from WHO and The Global Fund for international health projects including Fiji HIV response.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Kirby Institute is an academic health research institute at UNSW Sydney that conducts infectious disease research across HIV, viral hepatitis, sexually transmissible infections, HPV, COVID-19 and emerging infections, First Nations health, and global health. It delivers clinical trials, epidemiological surveillance, immunovirology studies, public health interventions, research training through the CHART Program and David Cooper Scholarship, and publishes annual surveillance reports through an interactive data portal.

Product overview

The Kirby Institute is a world-leading health research institute at UNSW Sydney that works to eliminate infectious diseases globally. Rather than a commercial product company, it operates as an academic research institution offering research programs focused on HIV, viral hepatitis, sexual health, HPV, COVID-19, First Nations health, and global health. The institute provides research training through the CHART Program and David Cooper Scholarship, and publishes surveillance data through annual reports and interactive dashboards. Its work encompasses clinical trials, epidemiology, immunovirology, and public health interventions across 14 research programs with over 1000 collaborations in 53 countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Research Programs in Infectious Diseases Fourteen research programs spanning HIV, viral hepatitis, sexual health, HPV, COVID-19 and emerging infections, First Nations health, and global health. Programs include epidemiology and surveillance, clinical trials and cohorts, immunovirology, biostatistics and modelling, health economics and health systems, public health interventions, new diagnostic approaches, social and behavioural sciences, and capacity building. Used by government funders, global health agencies, and collaborating academic and clinical researchers.
• Cooper HIV/AIDS Research Training (CHART) Program Education and training initiative that expands the number of skilled and experienced HIV researchers in the Asia-Pacific region while addressing local HIV priorities. Open to early-career researchers from partner institutions across the region.
• David Cooper Scholarship Postgraduate research scholarship supporting students at the Kirby Institute, named in honour of the institute's inaugural director Professor David Cooper AC.
• Annual Surveillance Reports and Interactive Data Portal Annual surveillance reports and interactive data dashboards (data.kirby.unsw.edu.au) tracking HIV, hepatitis, and sexually transmissible infections in Australia. Provides public health surveillance data to government, researchers, media, and the community.
• David Cooper Memorial Fund Memorial fundraising vehicle supporting the Kirby Institute's research, accepting donations in honour of founding Director Professor David Cooper AC.

Quantifiable outcome

• Transformed HIV from terminal diagnosis to manageable chronic illness treatable by one pill a day
• +3 more outcomes

Named customers4 records

Segments7 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Nine partnerships are on record, tiered core and secondary.

• Australian Government (Department of Health)coreStrategic or Co-development Partner · 13 February 2024Australian Government provided nearly $5 million funding to expand point-of-care hepatitis C testing nationally. The project involves over 150 stakeholders including healthcare providers, researchers, and policymakers working to scale successful pilot programs to improve diagnosis and treatment rates.
• Healthcare Providers and Community OrganizationscoreStrategic or Co-development PartnerOver 150 stakeholders including healthcare providers, community organizations, and policymakers collaborating on hepatitis C testing expansion in community and prison settings.
• World Health Organization (WHO)coreStrategic or Co-development PartnerWHO commissioned joint rapid assessment with UNDP and The Global Fund to identify gaps in Fiji's HIV response, particularly regarding harm reduction services. Kirby Institute conducted assessment identifying syringe scarcity and stigma as barriers.
• Fiji National UniversitycoreStrategic or Co-development PartnerCollaborated on rapid assessment of HIV epidemic in Fiji, contributing local expertise and institutional capacity to the joint WHO-commissioned study.
• Australian Injecting and Illicit Drug Users League (AIVL)coreStrategic or Co-development PartnerPartnered on rapid assessment examining unsafe injecting practices and harm reduction gaps in Fiji's HIV response.
• UNSW Medicine and HealthcoreStrategic or Co-development PartnerKirby Institute is part of UNSW Faculty of Medicine and Health, with shared resources, facilities, and collaborative research across departments.
• St Vincent's Centre for Applied Medical ResearchcoreStrategic or Co-development PartnerLong-standing collaboration on HIV research including clinical trials, immunological studies, and NSW HIV Reference laboratory operations.
• NSW Health (HIV Reference Laboratory)coreStrategic or Co-development PartnerKirby Institute provides oversight of the NSW State HIV Reference laboratory through Professor Kelleher's staff specialist role at St Vincent's Hospital.
• NSW HIV PRISM PartnershipsecondaryStrategic or Co-development PartnerCo-presenting Implementation Research Practice and Evaluation Seminar Series as part of the Partnership's activities.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Peter Doherty Institute for Infection and Immunity: Joint University of Melbourne and Royal Melbourne Hospital institute focused on infection and immunity research. Directly comparable as an Australian academic infectious-disease research institute with overlapping virology, immunology, and pandemic-preparedness mandates.
• Burnet Institute: Australian medical research institute with strong focus on infectious diseases, viral hepatitis, HIV, and global health in the Asia-Pacific region. Closely comparable mission, geographic footprint, and funding model (grant-funded, international partnerships).
• Walter and Eliza Hall Institute of Medical Research (WEHI): Australia's oldest medical research institute, also based at a major university (University of Melbourne), conducting research in immunology, infectious diseases, and cancer biology. Comparable scale (~1,000+ staff) and academic-affiliated R&D model.
• London School of Hygiene & Tropical Medicine (LSHTM): UK-based university specializing in public health and tropical/infectious-disease research with strong Asia-Pacific and global health programs. Comparable university-affiliated model, surveillance expertise, and global infectious-disease research footprint.

Broad incumbents

• Pasteur Institute: Global flagship infectious-disease research organization with century-long track record across virology, immunology, and epidemiology. Comparable mission and global surveillance role, though with much broader scope and resources than Kirby.
• The Francis Crick Institute: Major UK biomedical discovery institute covering infectious disease and immunology among other areas. Comparable as a large, grant-funded academic research institute with technology platforms and significant headcount.
• NIAID (National Institute of Allergy and Infectious Diseases): US NIH institute with global leadership in HIV/AIDS, hepatitis, STI, and emerging infectious-disease research. Comparable thematic focus and grant-funding model, though at vastly larger scale and as a government body.
• Centers for Disease Control and Prevention (CDC): US federal agency with global surveillance, outbreak response, and infectious-disease research functions directly comparable to Kirby's epidemiology and surveillance programs, though operating as a much larger government agency.
• Wellcome Trust (Wellcome Sanger Institute & Africa Health Research Institute): Major global charitable foundation funding infectious-disease and global-health research including Sanger's pathogen genomics work. Comparable as a long-horizon, grant-funded infectious-disease research ecosystem with global reach.

Regional players

• Institut Pasteur du Cambodge / International Pasteur Network affiliates: Regional Pasteur institute in Cambodia that runs infectious-disease surveillance and research across Southeast Asia. Comparable Asia-Pacific infectious-disease research mandate and surveillance focus, though smaller in scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/the-kirby-institute
• Xx.com/KirbyInstitute
• Facebookfacebook.com/KirbyInstitute

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kirby Institute